New research coming out of the University of Rochester suggests that inducing neurogenesis could be a possible treatment option for Huntington’s Disease.
Huntington’s Disease (HD) is a rare, autosomal dominant disease. The effects of HD are generally both physical and mental. Those afflicted with HD generally have erratic movements, slurring of speech, unsteady walking and uncoordinated facial expressions. As the disease progresses, patients typically lose the ability to feed themselves and require full-time care. Cognitively, patients lose their spatial skills, abstract thinking, planning and ability to learn new skills.
HD, unfortunately, has an extremely late onset which typically means the affected individual already has a family. Since HD is a dominant gene, only one parent must have the mutation to pass it on to their kids. The disease is caused by a number of repeats in the Interesting Transcript 15 gene, which encodes the huntington protein. Those with HD exhibit neurodegeneration throughout the brain, the neostratium in particular. The exact role of this protein in neurodegeneration, however, is still unknown.
Research headed by Sung-Rae Cho at the University of Rochester shows that inducing neurogenesis in striatal neurons slows the onset of HD, increasing life expectancy and reducing cognitive impairments in mice.
Details about the study after the jump
Read the rest of this entry